Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The objective of the study is assess the efficacy and safety of Trastuzumab in combination
with Capecitabine+Oxaliplatin as first-line treatment of patients with advanced or metastatic
gastric cancer or gastro-esophageal junction, (HER2)-positive.
Phase:
Phase 2
Details
Lead Sponsor:
Fundación para el Progreso de la Oncología en Cantabria